Delivery Order SPE2DB22D1106-SPE2DB25FFCD4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,152.08 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,703.65 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol vaginal rings on June 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,247.66 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings, with completion scheduled for October 23, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,625.98 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings on August 19, 2025, with completion scheduled for August 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract utilizes firm fixed pricing with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,579.61 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contraceptive pharmaceutical product will support federal medical supply needs,...
- The Defense Logistics Agency awarded a delivery order valued at $2,604.30 to AmerisourceBergen Drug Corp for the supply of Etonogestrel-EE vaginal rings, with an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on October 27, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,261.34 delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings under a firm fixed-price contract. The award, issued on September 2, 2025, with completion targeted for September 3, 2025, represents a small-value pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $2,386.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings, with completion scheduled for September 16, 2025. This non-set-aside contract represents a routine pharmaceutical procurement through the federal medical supply chain, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is a child contract under...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,254.15 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings. This order, issued on May 30, 2025, with completion targeted for June 2, 2025, represents a small-value pharmaceutical supply transaction supporting federal medical procurement needs. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp will perform this work from its...
- The Defense Logistics Agency awarded a $3,586.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings, with a completion date of September 15, 2025. This delivery order, issued on September 12, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, direct order placed against AmerisourceBergen's existing contract vehicle with the DLA. This delivery...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCD4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,345.05 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings under a firm fixed-price contract with an ultimate completion date of August 8, 2025. This non-set-aside delivery order was competitively awarded and represents a pharmaceutical supply fulfillment within the company's broader federal contracting portfolio. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The arrangement reflects DLA's strategy of leveraging prime vendor relationships to efficiently distribute pharmaceutical commodities across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/7/25 |